Cutoff SUVR of [F]Florapronol PET for Differentiating Alzheimer's Dementia from Normal Controls: Insights from ROC Analysis and Partial Volume Correction.
Journal:
Nuclear medicine and molecular imaging
Published Date:
Feb 20, 2025
Abstract
OBJECTIVES: The primary endpoint of this study is to establish a reliable SUVR cutoff threshold to distinguish patients with Alzheimer's disease (AD), excluding those with mild cognitive impairment (MCI), from normal control (NC) individuals using [F]florapronol PET imaging and deep learning-based automated quantification software. The secondary endpoint is to evaluate whether combining partial volume correction (PVC) with SUVR analysis improves diagnostic accuracy in detecting AD.
Authors
Keywords
No keywords available for this article.